title: Risk of CNS relapse after systemic relapse of childhood acute lymphoblastic leukemia.
authors.affiliation: Department of Pediatrics, Freie Universität, Berlin, FRG.
authors.forename: R
authors.initials: R
authors.lastname: Fengler
authors.forename: R
authors.initials: R
authors.lastname: Hartmann
authors.forename: U
authors.initials: U
authors.lastname: Bode
authors.forename: G
authors.initials: G
authors.lastname: Janka
authors.forename: H
authors.initials: H
authors.lastname: Jürgens
authors.forename: H
authors.initials: H
authors.lastname: Riehm
authors.forename: G
authors.initials: G
authors.lastname: Henze
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000453:epidemiology* / Q000517:prevention & control; D002648:Child; D005260:Female; D005860:Germany, West / Q000453:epidemiology; D006801:Humans; D007262:Infusions, Intravenous; D007278:Injections, Spinal; D015993:Life Tables; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage; D015337:Multicenter Studies as Topic; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000453:epidemiology / Q000473:pathology*; D012074:Remission Induction; D013120:Spinal Cord Neoplasms / Q000453:epidemiology* / Q000517:prevention & control
chemical_list: D008727:Methotrexate